Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M McCune

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Federation Proceedings|April 1, 1976
The immunoglobulin-like structure of human histocompatibility antigensJ L Strominger, R E Humphreys, J M McCune, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouseH Kaneshima, C C Shih, R Namikawa, et al.
Nature|December 6, 1990
Today's SCID-hu mouseH Kaneshima, C Baum, B Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouseB A Vandekerckhove, J F Krowka, J M McCune, et al.
The Journal of Experimental Medicine|December 22, 1999
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv miceD Dittmer, C Stoddart, R Renne, et al.
Journal of Virology|March 21, 2008
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus controlBrinda Emu, Elizabeth Sinclair, Hiroyu Hatano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanismsG Kovalev, K Duus, L Wang, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entryR Datema, L Rabin, M Hincenbergs, et al.
Cell|April 8, 1988
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virusJ M McCune, L B Rabin, M B Feinberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Federation Proceedings|April 1, 1976
The immunoglobulin-like structure of human histocompatibility antigensJ L Strominger, R E Humphreys, J M McCune, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouseH Kaneshima, C C Shih, R Namikawa, et al.
Nature|December 6, 1990
Today's SCID-hu mouseH Kaneshima, C Baum, B Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouseB A Vandekerckhove, J F Krowka, J M McCune, et al.
The Journal of Experimental Medicine|December 22, 1999
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv miceD Dittmer, C Stoddart, R Renne, et al.
Journal of Virology|March 21, 2008
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus controlBrinda Emu, Elizabeth Sinclair, Hiroyu Hatano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanismsG Kovalev, K Duus, L Wang, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entryR Datema, L Rabin, M Hincenbergs, et al.
Cell|April 8, 1988
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virusJ M McCune, L B Rabin, M B Feinberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
Pageof 9